| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |